Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Gilead Sciences (NQ: GILD )

69.02 USD +0.37 (+0.54%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jul 23, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 3,524,312
Open 68.88
Bid (Size) 68.88 (7)
Ask (Size) 69.10 (2)
Prev. Close 68.65
Today's Range 68.64 - 69.34
52wk Range 56.56 - 76.80
Shares Outstanding 1,254,178,166
Dividend Yield 4.11%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
BioNTech to Acquire Kite’s Neoantigen TCR Cell Therapy R&D Platform and Manufacturing Facility in Gaithersburg, MD
BioNTech SE (Nasdaq: BNTX, “BioNTech”) and Kite, a Gilead Company (Nasdaq: GILD, “Kite”) today announced the two companies have entered into a purchase agreement for BioNTech to acquire Kite’s solid... 
From Business Wire News Releases
BioNTech to Acquire Kite’s Neoantigen TCR Cell Therapy R&D Platform and Manufacturing Facility in Gaithersburg, MD
From GlobeNewswire News Releases

Performance

YTD
+14.82%
+14.82%
1 Month
+3.56%
+3.56%
3 Month
+5.41%
+5.41%
6 Month
+3.11%
+3.11%
1 Year
-8.66%
-8.66%

More News

Read More
New Phase 3 Data Support the Sustained, Long-Acting Efficacy of Lenacapavir, Gilead's Investigational HIV-1 Capsid Inhibitor
From Business Wire News Releases
Four-Year Biktarvy® Data Presented at IAS 2021 Demonstrate High Efficacy and Durable Viral Suppression in Treatment-Naïve Adults
From Business Wire News Releases
Gilead Sciences to Release Second Quarter 2021 Financial Results on Thursday, July 29, 2021
From Business Wire News Releases
iShares Biotechnology ETF Experiences Big Inflow
Tags ETFs
From ETF Channel
Why This Company’s Covid-19 Vaccine Is Just the Beginning
Tags PFE Market Insight, Financial Articles NASDAQ:BNTX,NYSE:PFE,NASDAQ:GILD
From InvestorPlace
Noteworthy Tuesday Option Activity: HUM, DISH, GILD
Tags Stocks
From Market News Video
Understanding Gilead Sciences's Unusual Options Activity
Tags BZI/UOA Market News GILD
From Benzinga
The FDA may not fully approve a COVID-19 vaccine until January. Here’s why
Tags GILD BNTX MRNA
From MarketWatch
Healthcare ETFs in Focus as Q2 Earnings Unfold
Tags ETFs Market News
From Blogs - TalkMarkets
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.